<DOC>
	<DOCNO>NCT01113229</DOCNO>
	<brief_summary>To demonstrate combine used oxytocin misoprostol prevent post partum haemorrhage well oxytocin alone , follow vaginal birth 36 42 week .</brief_summary>
	<brief_title>Combined Use Oxytocin Misoprostol Prevention Post Partum Haemorrhage</brief_title>
	<detailed_description>Objective : To demonstrate combine used oxytocin misoprostol prevent post partum haemorrhage well oxytocin alone , follow vaginal birth 36 42 week ' . Method : Double blind Randomized control trial two center 30 month . Treatment : Patients randomly allocate one two follow group : Group A : 10 UI oxytocin IV delivery anterior shoulder newborn two misoprostol tablet take orally ( 400Âµg ) follow cord clamp . Group B : 10 UI oxytocin IV delivery anterior shoulder newborn two placebo tablet take orally follow cord clamp . Number patient : 1550 patient per group ( one third reduction occurrence alpha beta set 0.05 0.20 respectively ) . Patients include study 48 hour .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Women &gt; 18 year , first stage normal labor , 36 42 week , epidural analgesia inform sign consent Cesarean section delivery , clot disorder , prostaglandin allergy , absent consent .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Post Partum Haemorrhage ,</keyword>
	<keyword>oxytocin ,</keyword>
	<keyword>misoprostol ,</keyword>
	<keyword>prevention ,</keyword>
	<keyword>delivery .</keyword>
</DOC>